VH genes in patients with chronic lymphocytic leukemia defined by mutated VH genes
Patient . | ID* . | Lymphocyte count (×109 L−1) . | VH* . | Percentage homology to GL* . |
---|---|---|---|---|
AW | 68 | 61.8 | V3-48 | 97 |
CS | 63 | 21.1 | V3-48 | 97 |
CW | 58 | 49.6 | V4-34 | 91 |
DF | 69 | 12.8 | V3-15 | 94 |
JB | 80 | 9.0 | V4-34 | 95 |
JL | 60 | 19.7 | V3-07 | 92 |
LS | 65 | 8.4 | V3-23 | 92 |
NO | 73 | 35.6 | V3-15 | 94 |
WB1 | 84 | 44.9 | V2-05 | 91 |
Patient . | ID* . | Lymphocyte count (×109 L−1) . | VH* . | Percentage homology to GL* . |
---|---|---|---|---|
AW | 68 | 61.8 | V3-48 | 97 |
CS | 63 | 21.1 | V3-48 | 97 |
CW | 58 | 49.6 | V4-34 | 91 |
DF | 69 | 12.8 | V3-15 | 94 |
JB | 80 | 9.0 | V4-34 | 95 |
JL | 60 | 19.7 | V3-07 | 92 |
LS | 65 | 8.4 | V3-23 | 92 |
NO | 73 | 35.6 | V3-15 | 94 |
WB1 | 84 | 44.9 | V2-05 | 91 |
ID number, VH gene use, % homology to germline (GL) V gene are as reported previously.5
Partial karyotype of predominant clone in each patient was reported previously.5